[Collagen synthesis inhibition by D-penicillamine in patients with chronic, aggressive hepatitis].
D002614:Chelating Agents / Q000494:pharmacology; D002908:Chronic Disease; D003094:Collagen / Q000037:antagonists & inhibitors* / Q000378:metabolism; D003238:Connective Tissue / Q000187:drug effects; D003545:Cysteine / Q000037:antagonists & inhibitors; D005260:Female; D006501:Hepatic Encephalopathy / Q000517:prevention & control; D006505:Hepatitis / Q000188:drug therapy* / Q000201:enzymology; D006801:Humans; D008875:Middle Aged; D010396:Penicillamine / Q000627:therapeutic use*; D011239:Prednisolone / Q000627:therapeutic use
D002614:Chelating Agents; D003094:Collagen; D011239:Prednisolone; D010396:Penicillamine; D003545:Cysteine
Kollagensynthese-Hemmung durch D-Penicillamin bei chronisch aggressiver Hepatitis.